Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions

被引:99
作者
Liu, Enqi
Morimoto, Masatoshi
Kitajima, Shuji
Koike, Tomonari
Yu, Ying
Shiiki, Hideo
Nagata, Michio
Watanabe, Teruo
Fan, Jianglin
机构
[1] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Chuo City, Yamanashi 4093898, Japan
[2] Xi An Jiao Tong Univ, Lab Anim Ctr, Xian 710049, Peoples R China
[3] Saga Univ, Analyt Res Ctr Expt Sci, Saga 840, Japan
[4] Uda City Hosp, Dept Nephrol, Nara, Japan
[5] Univ Tsukuba, Dept Mol Pathol, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 18卷 / 07期
关键词
D O I
10.1681/ASN.2006010075
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial growth factor (VEGF) is an important mediator in maintaining normal kidney functions. In addition, several lines of evidence suggest that upregulation of VEGF in glomeruli may be associated with or cause renal dysfunction such as diabetic nephropathy. For elucidation of the pathologic consequences of high levels of VEGF in glomeruli, transgenic (Tg) rabbits that express human VEGF,,, isoform in both kidney and liver under the control of the human a-l-antitrypsin promoter were generated and characterized. With the use of heterozygous Tg rabbits and their littermates aged 8 to 55 wk, renal functions and structures were investigated. Compared with control rabbits, Tg rabbits exhibited progressive proteinuria with increased GFR at the early stage and decreased GFR at the later stage. Histologic examinations revealed that Tg rabbit kidneys were characterized by considerable glomerular hypertrophy as a result of increased proliferation of both glomerular capillaries and mesangial cells accompanied by prominent podocyte hypertrophy. With increasing age starting from 20 wk, Tg rabbit kidneys showed prominent formation of microaneurysms and capillary proliferation at the vascular pole area. At a later stage (55 wk), many glomeruli showed sclerosis and tuft collapse with the formation of glomerular cysts on a background of tubular atrophy and interstitial fibrosis. This study provides the first evidence that increased expression of VEGF in glomeruli directly causes the glomerular hypertrophy that is associated with proteinuria, suggesting that VEGF exerts multiple effects on the glomerular pathophysiologic processes.
引用
收藏
页码:2094 / 2104
页数:11
相关论文
共 41 条
[1]  
BROWN SA, 1994, AM J VET RES, V55, P1470
[2]   Podocyte-derived vascular endothelial growth factor mediates the stimulation of α3(IV) collagen production by transforming growth factor-β 1 in mouse podocytes [J].
Chen, S ;
Kasama, Y ;
Lee, JS ;
Jim, B ;
Marin, M ;
Ziyadeh, FN .
DIABETES, 2004, 53 (11) :2939-2949
[3]   Angiotensin II stimulates α3(IV) collagen production in mouse podocytes via TGF-β and VEGF signalling:: implications for diabetic glomerulopathy [J].
Chen, SD ;
Lee, JS ;
Iglesias de la Cruz, MC ;
Wang, A ;
Izquierdo-Lahuerta, A ;
Gandhi, NK ;
Danesh, FR ;
Wolf, G ;
Ziyadeh, FN .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (07) :1320-1328
[4]   Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes [J].
Cooper, ME ;
Vranes, D ;
Youssef, S ;
Stacker, SA ;
Cox, AJ ;
Rizkalla, B ;
Casley, DJ ;
Bach, LA ;
Kelly, DJ ;
Gilbert, RE .
DIABETES, 1999, 48 (11) :2229-2239
[5]  
De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993
[6]   Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases [J].
Eremina, V ;
Sood, M ;
Haigh, J ;
Nagy, A ;
Lajoie, G ;
Ferrara, N ;
Gerber, HP ;
Kikkawa, Y ;
Miner, JH ;
Quaggin, SE .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :707-716
[7]   Transgenic rabbits as therapeutic protein bioreactors and human disease models [J].
Fan, JL ;
Watanabe, T .
PHARMACOLOGY & THERAPEUTICS, 2003, 99 (03) :261-282
[8]   Vascular endothelial growth factor: Basic science and clinical progress [J].
Ferrara, N .
ENDOCRINE REVIEWS, 2004, 25 (04) :581-611
[9]   Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody [J].
Flyvbjerg, A ;
Dagnæs-Hansen, F ;
De Vriese, AS ;
Schrijvers, BF ;
Tilton, RG ;
Rasch, R .
DIABETES, 2002, 51 (10) :3090-3094
[10]   Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes [J].
Foster, RR ;
Hole, R ;
Anderson, K ;
Satchell, SC ;
Coward, RJ ;
Mathieson, PW ;
Gillatt, DA ;
Saleem, MA ;
Bates, DO ;
Harper, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 284 (06) :F1263-F1273